Skip to main content
Top
Published in: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 1/2017

Open Access 01-12-2017 | Original research

Intoxication with GHB/GBL: characteristics and trends from ambulance-attended overdoses

Authors: Desiree Madah-Amiri, Lars Myrmel, Guttorm Brattebø

Published in: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine | Issue 1/2017

Login to get access

Abstract

Background

Overdoses from so-called “club drugs” (GHB/GBL) have become a more frequent cause of overdoses attended by ambulance services. Given its availability, affordability, and lack of awareness of risks, there is a common misconception among users that the drug is relatively safe.

Methods

This study reviewed ambulance records in Bergen, Norway between 2009 and 2015 for cases of acute poisonings, particularly from suspected GHB/GBL intoxication.

Results

In total, 1112 cases of GHB and GBL poisoning were identified. GHB was suspected for 995 (89%) of the patients. Men made up the majority of the cases (n = 752, 67.6%) with a median age of 27 years old. Temporal trends for GHB/GBL overdoses displayed a late-night, weekend pattern. The most frequent initial symptoms reported were unconsciousness, or reduced consciousness. Most of the patients required further treatment and transport. During the period from 2009 to 2015, there was a nearly 50% decrease in GHB/GBL overdoses from 2013 to 2014.

Discussion

The characteristics of GHB/GBL overdose victims shed light on this patient group. The decrease in incidence over the years may be partly due to a legal ban on GBL in Norway, declared in 2010. It may also be due to an increase in the use of MDMA/ecstasy.

Conclusion

The review of ambulance records on the prehospital treatment of overdoses can be beneficial in monitoring, preparing, and prevention efforts aimed to benefit this vulnerable group.
Literature
1.
go back to reference Hovda KE, et al. Acute poisonings treated in hospitals in Oslo: a one-year prospective study (I): pattern of poisoning. Clin Toxicol. 2008;46:35–41.CrossRef Hovda KE, et al. Acute poisonings treated in hospitals in Oslo: a one-year prospective study (I): pattern of poisoning. Clin Toxicol. 2008;46:35–41.CrossRef
2.
go back to reference Rygnestad T, Fagerhaug O. Acute deliberate self-poisonings in the area of Trondheim, 1978-2002. Tidsskr Nor Laegeforen. 2004;124:2736–9.PubMed Rygnestad T, Fagerhaug O. Acute deliberate self-poisonings in the area of Trondheim, 1978-2002. Tidsskr Nor Laegeforen. 2004;124:2736–9.PubMed
4.
go back to reference Lund C, et al. Outpatient treatment of acute poisonings in Oslo: poisoning pattern, factors associated with hospitalization, and mortality. Scand J Trauma Resusc Emerg Med. 2012;20:1.CrossRefPubMedPubMedCentral Lund C, et al. Outpatient treatment of acute poisonings in Oslo: poisoning pattern, factors associated with hospitalization, and mortality. Scand J Trauma Resusc Emerg Med. 2012;20:1.CrossRefPubMedPubMedCentral
5.
go back to reference Vallersnes OM, et al. Patients presenting with acute poisoning to an outpatient emergency clinic: a one-year observational study in Oslo, Norway. BMC Emerg Med. 2015;15:18.CrossRefPubMedPubMedCentral Vallersnes OM, et al. Patients presenting with acute poisoning to an outpatient emergency clinic: a one-year observational study in Oslo, Norway. BMC Emerg Med. 2015;15:18.CrossRefPubMedPubMedCentral
6.
go back to reference Persson SA, et al. GHB--dangerous, addictive and uncontrollable “party drug”. Lakartidningen. 2001;98:4026–31. 4033-5PubMed Persson SA, et al. GHB--dangerous, addictive and uncontrollable “party drug”. Lakartidningen. 2001;98:4026–31. 4033-5PubMed
7.
go back to reference Knudsen K, Greter J, Verdicchio M. High mortality rates among GHB abusers in Western Sweden. Clin Toxicol (Phila). 2008;46:187–92.CrossRef Knudsen K, Greter J, Verdicchio M. High mortality rates among GHB abusers in Western Sweden. Clin Toxicol (Phila). 2008;46:187–92.CrossRef
8.
go back to reference Knudsen K, et al. GHB, GBL and butanediol poisonings--a serious problem in Western Sweden. Lakartidningen. 2005;102:3294–6. 3299PubMed Knudsen K, et al. GHB, GBL and butanediol poisonings--a serious problem in Western Sweden. Lakartidningen. 2005;102:3294–6. 3299PubMed
9.
go back to reference Simonsen KW, et al. Fatal poisoning in drug addicts in the Nordic countries in 2012. Forensic Sci Int. 2015;248:172–80.CrossRefPubMed Simonsen KW, et al. Fatal poisoning in drug addicts in the Nordic countries in 2012. Forensic Sci Int. 2015;248:172–80.CrossRefPubMed
12.
go back to reference Dyer JE, Haller CA. Medical toxicology. In: g-hydroxybutyrate, g-butyramide olactone, and 1.4-butanediol. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. Dyer JE, Haller CA. Medical toxicology. In: g-hydroxybutyrate, g-butyramide olactone, and 1.4-butanediol. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004.
13.
go back to reference Schep LJ, et al. The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol. Clin Toxicol (Phila). 2012;50:458–70.CrossRef Schep LJ, et al. The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol. Clin Toxicol (Phila). 2012;50:458–70.CrossRef
14.
15.
go back to reference Carter LP, et al. Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse. Drug Alcohol Depend. 2009;104:1–10.CrossRefPubMedPubMedCentral Carter LP, et al. Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse. Drug Alcohol Depend. 2009;104:1–10.CrossRefPubMedPubMedCentral
16.
go back to reference Couper FJ, Marinetti LJ. Gamma-Hydroxybutyrate (GHB) - Effects on human performance and behavior. Forensic Sci Rev. 2002;14:101–21.PubMed Couper FJ, Marinetti LJ. Gamma-Hydroxybutyrate (GHB) - Effects on human performance and behavior. Forensic Sci Rev. 2002;14:101–21.PubMed
17.
go back to reference Lenz D, Rothschild MA, Kroner L. Intoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone. Ther Drug Monit. 2008;30:755–61.CrossRefPubMed Lenz D, Rothschild MA, Kroner L. Intoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone. Ther Drug Monit. 2008;30:755–61.CrossRefPubMed
18.
go back to reference Miotto K, et al. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. Am J Addict. 2001;10:232–41.CrossRefPubMed Miotto K, et al. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. Am J Addict. 2001;10:232–41.CrossRefPubMed
19.
go back to reference Wood DM, et al. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD). QJM. 2008;101:23–9.CrossRefPubMed Wood DM, et al. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD). QJM. 2008;101:23–9.CrossRefPubMed
20.
go back to reference Lettieri J, Fung HL. Improved pharmacological activity via pro-drug modification: comparative pharmacokinetics of sodium gamma-hydroxybutyrate and gamma-butyrolactone. Res Commun Chem Pathol Pharmacol. 1978;22:107–18.PubMed Lettieri J, Fung HL. Improved pharmacological activity via pro-drug modification: comparative pharmacokinetics of sodium gamma-hydroxybutyrate and gamma-butyrolactone. Res Commun Chem Pathol Pharmacol. 1978;22:107–18.PubMed
21.
go back to reference Goodwin AK, et al. Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology. 2009;204:465–76.CrossRefPubMedPubMedCentral Goodwin AK, et al. Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology. 2009;204:465–76.CrossRefPubMedPubMedCentral
22.
go back to reference GBL on the narcotic list, in 20/2010, Norwegian Directorate of Health, 2010. GBL on the narcotic list, in 20/2010, Norwegian Directorate of Health, 2010.
23.
go back to reference Knudsen K, Jonsson U, Abrahamsson J. Twenty-three deaths with gamma-hydroxybutyrate overdose in western Sweden between 2000 and 2007. Acta Anaesthesiol Scand. 2010;54:987–92.CrossRefPubMed Knudsen K, Jonsson U, Abrahamsson J. Twenty-three deaths with gamma-hydroxybutyrate overdose in western Sweden between 2000 and 2007. Acta Anaesthesiol Scand. 2010;54:987–92.CrossRefPubMed
24.
go back to reference Wong CG, et al. Gamma-hydroxybutyric acid: neurobiology and toxicology of a recreational drug. Toxicol Rev. 2004;23:3–20.CrossRefPubMed Wong CG, et al. Gamma-hydroxybutyric acid: neurobiology and toxicology of a recreational drug. Toxicol Rev. 2004;23:3–20.CrossRefPubMed
25.
go back to reference Brennan R, Van Hout MC. Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups. J Psychoactive Drugs. 2014;46:243–51.CrossRefPubMed Brennan R, Van Hout MC. Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups. J Psychoactive Drugs. 2014;46:243–51.CrossRefPubMed
26.
go back to reference Krayeva YV, et al. Pre-hospital management and outcome of acute poisonings by ambulances in Yekaterinburg, Russia. Clin Toxicol (Phila). 2013;51:752–60.CrossRef Krayeva YV, et al. Pre-hospital management and outcome of acute poisonings by ambulances in Yekaterinburg, Russia. Clin Toxicol (Phila). 2013;51:752–60.CrossRef
27.
go back to reference Simpson PM, et al. Epidemiology of ambulance responses to older people who have fallen in New South Wales, Australia. Australas J Ageing. 2013;32:171–6.CrossRefPubMed Simpson PM, et al. Epidemiology of ambulance responses to older people who have fallen in New South Wales, Australia. Australas J Ageing. 2013;32:171–6.CrossRefPubMed
28.
go back to reference Lloyd BK, McElwee PR. Trends over time in characteristics of pharmaceutical drug-related ambulance attendances in Melbourne. Drug Alcohol Rev. 2011;30:271–80.CrossRefPubMed Lloyd BK, McElwee PR. Trends over time in characteristics of pharmaceutical drug-related ambulance attendances in Melbourne. Drug Alcohol Rev. 2011;30:271–80.CrossRefPubMed
29.
go back to reference Degenhardt L, Copeland J, Dillon P. Recent trends in the use of “club drugs”: an Australian review. Subst Use Misuse. 2005;40:1241–56.CrossRefPubMed Degenhardt L, Copeland J, Dillon P. Recent trends in the use of “club drugs”: an Australian review. Subst Use Misuse. 2005;40:1241–56.CrossRefPubMed
31.
go back to reference European Monitoring Centre for Drugs and Drug Addiction Lisbon. European Drug Report in Trends and Developments, 2015. European Monitoring Centre for Drugs and Drug Addiction Lisbon. European Drug Report in Trends and Developments, 2015.
32.
go back to reference Madah-Amiri D, et al. Circumstances surrounding non-fatal opioid overdoses attended by ambulance services. Drug Alcohol Rev. 2017;36:288–94.CrossRefPubMed Madah-Amiri D, et al. Circumstances surrounding non-fatal opioid overdoses attended by ambulance services. Drug Alcohol Rev. 2017;36:288–94.CrossRefPubMed
33.
34.
35.
go back to reference Liechti ME, et al. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Drug Alcohol Depend. 2006;81:323–6.CrossRefPubMed Liechti ME, et al. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Drug Alcohol Depend. 2006;81:323–6.CrossRefPubMed
36.
go back to reference Holzer BM, et al. Ten-year trends in intoxications and requests for emergency ambulance service. Prehosp Emerg Care. 2012;16:497–504.CrossRefPubMed Holzer BM, et al. Ten-year trends in intoxications and requests for emergency ambulance service. Prehosp Emerg Care. 2012;16:497–504.CrossRefPubMed
37.
go back to reference McLaughlin MP. Alcohol-associated illness and injury and ambulance calls in a midwestern college town: a four-year retrospective analysis. Prehosp Emerg Care. 2010;14:485–90.CrossRefPubMed McLaughlin MP. Alcohol-associated illness and injury and ambulance calls in a midwestern college town: a four-year retrospective analysis. Prehosp Emerg Care. 2010;14:485–90.CrossRefPubMed
38.
go back to reference Foster S, et al. Temporal patterns of alcohol consumption and alcohol-related road accidents in young Swiss men: seasonal, weekday and public holiday effects. Alcohol Alcohol. 2015;50:565–72.CrossRefPubMed Foster S, et al. Temporal patterns of alcohol consumption and alcohol-related road accidents in young Swiss men: seasonal, weekday and public holiday effects. Alcohol Alcohol. 2015;50:565–72.CrossRefPubMed
39.
go back to reference O'Farrell A, et al. The burden of alcohol misuse on emergency in-patient hospital admissions among residents from a health board region in Ireland. Addiction. 2004;99:1279–85.CrossRefPubMed O'Farrell A, et al. The burden of alcohol misuse on emergency in-patient hospital admissions among residents from a health board region in Ireland. Addiction. 2004;99:1279–85.CrossRefPubMed
40.
go back to reference Lott S, Musshoff F, Madea B. Estimation of gamma-hydroxybutyrate (GHB) co-consumption in serum samples of drivers positive for amphetamine or ecstasy. Forensic Sci Int. 2012;221:98–101.CrossRefPubMed Lott S, Musshoff F, Madea B. Estimation of gamma-hydroxybutyrate (GHB) co-consumption in serum samples of drivers positive for amphetamine or ecstasy. Forensic Sci Int. 2012;221:98–101.CrossRefPubMed
41.
Metadata
Title
Intoxication with GHB/GBL: characteristics and trends from ambulance-attended overdoses
Authors
Desiree Madah-Amiri
Lars Myrmel
Guttorm Brattebø
Publication date
01-12-2017
Publisher
BioMed Central
DOI
https://doi.org/10.1186/s13049-017-0441-6

Other articles of this Issue 1/2017

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 1/2017 Go to the issue